Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.49

€2.49

0.360%
0.009
0.360%
-
 
15:44 / Tradegate WKN: A2JQV6 / Name: WELL Health Technologies / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Financial data and news for WELL Health Technologies

sharewise wants to provide you with the best news and tools for WELL Health Technologies, so we directly link to the best financial data sources.

News

WELL Health Reports Record Revenue, Adjusted EBITDA, and Net Income Results for Q4 and Full Year 2023 and Raises Revenue Guidance: https://www.irw-press.at/prcom/images/messages/2024/74021/WELLHealth_210324_PRCOM.001.png
WELL Health Reports Record Revenue, Adjusted EBITDA, and Net Income Results for Q4 and Full Year 2023 and Raises Revenue Guidance

-          WELL achieved record annual revenue of $776.1 million for 2023, an increase of 36% compared to the prior year. WELL achieved record quarterly revenues of $231.2 million in

WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024: https://www.irw-press.at/prcom/images/messages/2023/72648/WELLHealth111423_EN_PRcom.001.png
WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024

-          WELL achieved record quarterly revenues of $204.5 million and record Adjusted EBITDA(1) of $28.2 million in Q3-2023. This was WELL’s 19th consecutive quarter of record revenue

WELL Ventures Reports a New Investment and Successful Follow-on Fundraising Activity in its Portfolio with High Quality Capital Allocators
WELL Ventures Reports a New Investment and Successful Follow-on Fundraising Activity in its Portfolio with High Quality Capital Allocators

-          WELL Ventures is pleased to report that its portfolio companies continue to raise funds at attractive valuations with high quality capital allocators globally.

-          Sun Life